Results 21 to 30 of about 3,379 (229)

Comparison Between Ginkgo biloba and Betahistine in Treatment of Vertigo: A Prospective Comparative Study [PDF]

Journal of Rawalpindi Medical College
Objective: Vertigo significantly impairs balance and quality of life. Betahistine and standardized Ginkgo biloba extract (Ginbex) are commonly used treatments, but comparative data remain limited.
Muhammad Shuaib Khan, Sadia Chaudhry, Nida Riaz, S. Khan, Anique Ahmad Jamil, Abdur Rehman   +5 more
semanticscholar   +2 more sources

Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study

International Journal of General Medicine, 2014
Ovidiu Băjenaru,1 Adina Maria Roceanu,2 Silviu Albu,3 Viorel Zainea,4 Alexandru Pascu,4 Mădălina Gabriela Georgescu,4 Sebastian Cozma,5 Luigi Mărceanu,6 Dafin Fior Mureşanu7 1Department of Neurology, Carol Davila University of Medicine and Pharmacy ...
Băjenaru O, Roceanu AM, Albu S, Zainea V, Pascu A, Georgescu MG, Cozma S, Mărceanu L, Mureşanu DF   +8 more
doaj   +1 more source

Hearing function after betahistine therapy in patients with Ménière's disease

Brazilian Journal of Otorhinolaryngology, 2015
INTRODUCTION: Preventing or reversing hearing loss is challenging in Ménière's disease. Betahistine, as a histamine agonist, has been tried in controlling vertigo in patients with Ménière's disease, but its effectiveness on hearing problems is not known.
Seyed Javad Seyed Tootoonchi, Samad Ghiasi, Parvaneh Shadara, Simin Mirakhor Samani, Daniel Fadaei Fouladi   +4 more
doaj   +3 more sources

Maternal Betahistine Exposure and Pregnancy Outcomes: A Retrospective Cohort Study. [PDF]

Cureus
Background In the general population, betahistine has a good safety profile. However, there is insufficient data on betahistine use during pregnancy; safety and teratogenic risks are yet to be evaluated.
Alsaad D, Ahmed A, Elkassem W, Moursi A, Minisha F.   +4 more
europepmc   +2 more sources

Letter to the Editor in Response to "Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-Analysis" by Nishii et al. [PDF]

Neuropsychopharmacol Rep
Neuropsychopharmacology Reports, Volume 45, Issue 4, December 2025.
Farhan M.
europepmc   +2 more sources

Betahistine for tinnitus [PDF]

Cochrane Database of Systematic Reviews, 2018
Tinnitus is a symptom defined as the perception of sound in the absence of an external source. In England alone there are an estimated ¾ million general practice consultations every year where the primary complaint is tinnitus, equating to a major burden on healthcare services.
Inge, Wegner, Deborah A, Hall, Adriana Leni, Smit, Don, McFerran, Inge, Stegeman   +4 more
openaire   +3 more sources

Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo

International Journal of General Medicine, 2015
Svetlana Vyacheslavovna Morozova,1 Natalia Stepanovna Alekseeva,2 Sergey Vasilyevich Lilenko,3 Eduard Ivanovich Matsnev,4 Oleg Anatol'evich Melnikov51Department of Ear, Nose, and Throat, State Budgetary Educational Institution of Higher Professional ...
Morozova SV, Alekseeva NS, Lilenko SV, Matsnev EI, Melnikov OA   +4 more
doaj   +1 more source

High-Dose Betahistine Improves Cognitive Function in Patients With Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

Frontiers in Psychiatry, 2021
Background: There is currently no effective treatment for cognitive impairment associated with schizophrenia (CIAS). Recent studies have shown that increased histamine levels in the brain may help to improve CIAS symptoms.
Yongqian Wang, Xufeng Huang, Hongzhen Fan, Huimei An, Ting Ma, Qi Zhang, Wenxuan Zhao, Yajun Yun, Wenshuang Yang, Xiaolu Zhang, Zhiren Wang, Fude Yang   +11 more
doaj   +1 more source

Vestibular Paroxysmia Coexisting With Meige Syndrome: A Case Report. [PDF]

Clin Case Rep
ABSTRACT VP and MS are distinct clinical entities arising from the peripheral vestibular system and central extrapyramidal pathways, respectively. We report a rare case of a 69‐year‐old woman with coexistence of VP and MS. Individualized pharmacotherapy resolved vertigo and markedly improved blepharospasm.
Ding Y, Yin G, Dai Y, Qin F, Zeng X, Huang Q, Li Y.   +6 more
europepmc   +2 more sources

Analysis of factors affecting the success of betahistine treatment in patients with idiopathic subjective tinnitus

B-ENT, 2020
Objective: This study aimed to evaluate betahistine treatment efficacy and factors affecting the success of betahistine treatment in patients with subjective idiopathic tinnitus.
Mehmet Murat Gunay, Deniz Baklaci, Ihsan Kuzucu   +2 more
doaj   +3 more sources